ゼリア新薬工業(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4559/E00948ZERIA PHARMACEUTICAL CO., LTD.
公表日公表担保新規貸付前週比新規借入（自己）前週比新規借入（転貸）前週比
2020/03/19日証協無担保0株-100%15,300株+9999.99%8,000株+370.59%
2020/03/19日証協有担保101,759株-61.86%33,500株-59.49%68,467株-69.69%
2020/03/13日証協無担保1,200株-73.91%100株0%1,700株-32%
2020/03/13日証協有担保266,779株-33.47%82,700株-20.25%225,861株+183.79%
2020/03/06日証協無担保4,600株+206.67%0株0%2,500株+108.33%
2020/03/06日証協有担保401,000株+20.93%103,700株+66.19%79,586株-29.07%
2020/02/28日証協無担保1,500株-61.54%0株0%1,200株+50%
2020/02/28日証協有担保331,590株+27.91%62,400株-33.26%112,200株+111.7%
2020/02/21日証協無担保3,900株0%0株0%800株-27.6%
2020/02/21日証協有担保259,245株+232.85%93,500株+27.21%53,000株-13.26%
2020/02/14日証協無担保0株-100%0株0%1,105株-64.37%
2020/02/14日証協有担保77,886株-53.2%73,500株-21.47%61,099株+31.59%
2020/02/07日証協無担保500株-64.29%0株0%3,101株+138.54%
2020/02/07日証協有担保166,420株+44.22%93,600株+16.71%46,432株+0.72%
2020/01/31日証協無担保1,400株-65%0株0%1,300株-23.57%
2020/01/31日証協有担保115,394株+147.27%80,200株+110.5%46,100株+92.19%
2020/01/24日証協無担保4,000株-52.94%0株0%1,701株+750.5%
2020/01/24日証協有担保46,667株+114.38%38,100株-31.79%23,987株+36.94%
2020/01/17日証協無担保8,500株-17.48%0株0%200株-81.82%
2020/01/17日証協有担保21,768株-87.82%55,854株-8.02%17,516株-63.17%
2020/01/10日証協無担保10,300株0%0株0%1,100株+83.33%
2020/01/10日証協有担保178,788株+5008.23%60,727株+140.98%47,559株+446.66%
2019/12/30日証協無担保0株0%0株0%600株+20%
2019/12/30日証協有担保3,500株-94.65%25,200株+142.31%8,700株-87.68%
2019/12/27日証協無担保0株-100%0株0%500株+150%
2019/12/27日証協有担保65,417株-81.29%10,400株-80.62%70,640株+59.76%
2019/12/20日証協無担保3,200株0%0株0%200株-33.33%
2019/12/20日証協有担保349,564株-22.09%53,654株-26.12%44,216株-42.08%
2019/12/13日証協無担保0株0%0株0%300株-25%
2019/12/13日証協有担保448,673株+104.97%72,627株-0.58%76,343株+28.15%
2019/12/06日証協無担保0株0%0株0%400株0%
2019/12/06日証協有担保218,893株-0.49%73,054株+4465.88%59,575株-54.24%
2019/11/29日証協無担保0株0%0株0%400株+100%
2019/11/29日証協有担保219,977株-21.2%1,600株-91.19%130,200株+6.81%
2019/11/22日証協無担保0株0%0株0%200株+100%
2019/11/22日証協有担保279,157株+4.37%18,154株-82.95%121,900株+57.7%
2019/11/15日証協無担保0株0%0株0%100株-95.45%
2019/11/15日証協有担保267,471株+119.34%106,454株+2237.59%77,300株-43.25%

※株式分割は考慮していませんのでご注意ください。

Page Top